For RUNX1, mutation ranked first in all alternate types in breast invasive lobular carcinoma (8.02%), followed by breast invasive carcinoma NOS (4.11%), and breast invasive ductal carcinoma (3.10%). Here, RUNX1 is linked to invasive lobular breast carcinoma.